On March 14, 2023 LIDDS AB (publ) reported that the company will participate in two important events this spring. Firstly, the BIO-Europe Spring meeting, taking place in Basel between 20 and 22 March 2023 (Press release, Lidds, MAR 14, 2023, View Source [SID1234628689]). Secondly, the EACR Defence is the Best Attack: Immuno-Oncology Breakthroughs conference, taking place in Barcelona between 9 and 11 May 2023.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
LIDDS’ CEO Anders Månsson will participate in the BIO-Europe Spring meeting, which is physically organized in Basel, Switzerland. BIO-Europe is the premier European partnering event and provides LIDDS with opportunities for both collaboration and partner discussions as well as investor meetings. LIDDS’ attendance will be in conjunction with our partnership with Alira Health to drive forward our on-going business development activities.
LIDDS’ Head of Preclinical, Erwin Brenndörfer will attend the European Association for Cancer Research (EACR) meeting titled "Defence is the Best Attack: Immuno-Oncology Breakthroughs" after submitting an abstract on LIDDS’ Nanoimod project, and successfully being accepted to deliver a poster presentation. Erwin will share more details on the strong progress with this project as LIDDS prepares for a possible Phase I initiation this year.
For additional information, please contact
Anders Månsson, CEO
Phone: +46 (0)70 860 47 38
E-mail: [email protected]
Jenni Björnulfson, CFO
Phone: +46 (0)70 855 38 05
E-mail: [email protected]